Hepatomegaly News and Research

RSS
Gilead submits Truvada/TMC278 single-tablet regimen NDA to FDA

Gilead submits Truvada/TMC278 single-tablet regimen NDA to FDA

Gilead to present data of two Phase III trials evaluating Viread efficacy for HBV infection at The Liver Meeting 2010

Gilead to present data of two Phase III trials evaluating Viread efficacy for HBV infection at The Liver Meeting 2010

BARACLUDE sNDA receives FDA approval for treatment of CHB patients with decompensated liver disease

BARACLUDE sNDA receives FDA approval for treatment of CHB patients with decompensated liver disease

Annals of Internal Medicine publishes GRACE study data on HIV therapy

Annals of Internal Medicine publishes GRACE study data on HIV therapy

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

Gilead Sciences announces Quad regimen Phase II clinical trial results for HIV infection treatment

Pfizer to discontinue commercial availability of Mylotarg for AML in U.S.

Pfizer to discontinue commercial availability of Mylotarg for AML in U.S.

Varicella zoster infection causes severe autoimmune hepatitis

Varicella zoster infection causes severe autoimmune hepatitis

Bristol-Myers Squibb announces new results of Baraclude (entecavir) resistance monitoring program

Bristol-Myers Squibb announces new results of Baraclude (entecavir) resistance monitoring program